logo
‘Dragon prince' dinosaur discovery is changing how scientists understand T. rex

‘Dragon prince' dinosaur discovery is changing how scientists understand T. rex

CNN12-06-2025
Sign up for CNN's Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more.
CNN —
Scientists have identified a previously unknown 86 million-year-old dinosaur species that fills an early gap in the fossil record of tyrannosaurs, revealing how they evolved to become massive apex predators.
Researchers analyzing the species' remains have named it Khankhuuluu mongoliensis, which translates to 'dragon prince of Mongolia,' because it was small compared with its much larger relatives such as Tyrannosaurus rex, whose name means 'the tyrant lizard king.' The newly identified dinosaur was the closest known ancestor of tyrannosaurs and likely served as a transitional species from earlier tyrannosauroid species, according to the findings published Wednesday in the journal Nature.
Based on a reexamination of two partial skeletons uncovered in Mongolia's Gobi Desert in 1972 and 1973, the new study suggests that three big migrations between Asia and North America led tyrannosauroids to diversify and eventually reach a gargantuan size in the late Cretaceous Period before going extinct 66 million years ago.
'This discovery of Khankhuuluu forced us to look at the tyrannosaur family tree in a very different light,' said study coauthor Darla Zelenitsky, associate professor within the department of Earth, energy, and environment at the University of Calgary, in an email. 'Before this, there was a lot of confusion about who was related to who when it came to tyrannosaur species. What started as the discovery of a new species ended up with us rewriting the family history of tyrannosaurs.'
Multiple migrations over millions of years
Tyrannosaurs, known scientifically as Eutyrannosaurians, bring to mind hulking dinosaurs like Tyrannosaurus rex and Tarbosaurus, which weighed multiple metric tons and could take down equally large prey.
With short arms and massive heads, they walked on two legs and boasted sharp teeth, Zelenitsky said.
But tyrannosaurs didn't start out that way. They evolved from smaller dinosaurs before dominating the landscapes of North America and Asia between 85 million and 66 million years ago, the researchers said.
While Tarbosaurus, an ancestor of T. rex, clocked in at between 3,000 and 6,000 kilograms (6,613 pounds and 13,227 pounds), the fleet-footed Khankhuuluu mongoliensis likely weighed only around 750 kilograms (1,653 pounds), spanned just 2 meters (6.5 feet) at the hips and 4 meters (13 feet) in length, according to the study authors.
Comparing the two dinosaurs would be like putting a horse next to an elephant —Khankhuuluu would have reached T. rex's thigh in height, Zelenitsky said.
'Khankhuuluu was almost a tyrannosaur, but not quite,' Zelenitsky said. 'The snout bone was hollow rather than solid, and the bones around the eye didn't have all the horns and bumps seen in T. rex or other tyrannosaurs.'
Khankhuuluu mongoliensis, or a closely related ancestor species, likely migrated from Asia to North America across a land bridge between Alaska and Siberia that connected the continents 85 million years ago, Zelenitsky said.
Because of this migrant species, we now know that tyrannosaurs actually evolved first on the North American continent and remained there exclusively over the next several million years, she said. 'As the many tyrannosaur species evolved on the continent, they became larger and larger.'
Due to the poor fossil record, it's unclear what transpired in Asia between 80 million to 85 million years ago, she added. While some Khankhuuluu may have remained in Asia, they were likely replaced later on by larger tyrannosaurs 79 million years ago.
Meanwhile, another tyrannosaur species crossed the land bridge back to Asia 78 million years ago, resulting in the evolution of two related but very different subgroups of tyrannosaurs, Zelenitsky said. One was a gigantic, deep-snouted species, while the other known as Alioramins was slender and small. These smaller dinosaurs have been dubbed 'Pinocchio rexes' for their long, shallow snouts.
Both types of tyrannosaurs were able to live in Asia and not compete with each other because the larger dinosaurs were top predators, while Alioramins were mid-level predators going after smaller prey — think cheetahs or jackals in African ecosystems today, Zelenitsky said.
'Because of their small size, Alioramins were long thought to be primitive tyrannosaurs, but we novelly show Alioramins uniquely evolved smallness as they had 'miniaturized' their bodies within a part of the tyrannosaur family tree that were all otherwise giants,' Zelenitsky said.
One more migration happened as tyrannosaurs continued to evolve, and a gigantic tyrannosaur species crossed back into North America 68 million years ago, resulting in Tyrannosaurus rex, Zelenitsky said.
'The success and diversity of tyrannosaurs is thanks to a few migrations between the two continents, starting with Khankhuuluu,' she said. 'Tyrannosaurs were in the right place at the right time. They were able to take advantage of moving between continents, likely encountering open niche spaces, and quickly evolving to become large, efficient killing machines.'
Revisiting a decades-old find
The new findings support previous research suggesting that Tyrannosaurus rex's direct ancestor originated in Asia and migrated to North America via a land bridge and underscore the importance of Asia in the evolutionary success of the tyrannosaur family, said Cassius Morrison, a doctoral student of paleontology at University College London. Morrison was not involved in the new research.
'The new species provides essential data and information in part of the family tree with few species, helping us to understand the evolutionary transition of tyrannosaurs from small/ medium predators to large apex predators,' Morrison wrote in an email.
The study also shows that the Alioramini group, once considered distant relatives, were very close cousins of T. rex.
What makes the fossils of the new species so crucial is their age — 20 million years older than T. rex, said Steve Brusatte, professor and personal chair of Palaeontology and Evolution at the University of Edinburgh. Brusatte was not involved in the new study.
'There are so few fossils from this time, and that is why these scientists describe it as 'murky,'' Brusatte said. 'It has been a frustrating gap in the record, like if you suspected something really important happened in your family history at a certain time, like a marriage that started a new branch of the family or immigration to a new country, but you had no records to document it. The tyrannosaur family tree was shaped by migration, just like so many of our human families.'
With only fragments of fossils available, it's been difficult to understand the variation of tyrannosaurs as they evolved, said Thomas Carr, associate professor of biology at Carthage College in Wisconsin and director of the Carthage Institute of Paleontology. Carr was not involved in the new research. But the new study sheds light on the dinosaurs' diversity and clarifies which ones existed when — and how they overlapped with one another, he said.
More samples from the fossil record will provide additional clarity, but the new work illustrates the importance of reexamining fossils collected earlier.
'We know so much more about tyrannosaurs now,' Carr said. 'A lot of these historical specimens are definitely worth their weight in gold for a second look.'
When the fossils were collected half a century ago, they were only briefly described at the time, Brusatte said.
'So many of us in the paleontology community knew that these Mongolian fossils were lurking in museum drawers, waiting to be studied properly, and apt to tell their own important part of the tyrannosaur story,' he said. 'It's almost like there was a non-disclosure agreement surrounding these fossils, and it's now expired, and they can come out and tell their story.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eli Lilly and GSK drive South Korea's drug licensing activity
Eli Lilly and GSK drive South Korea's drug licensing activity

Yahoo

time12 hours ago

  • Yahoo

Eli Lilly and GSK drive South Korea's drug licensing activity

China's growth as a drug licensing hub is well-treaded, but a surge in deals in South Korea means it is also becoming a go-to destination for big pharma companies, according to market analysis. According to the GlobalData deal database, the deal value for South Korean drug licensing agreements has so far reached $7.68bn this year, marking a 113% increase from 2024. The out-licensing of South Korean drugs to international firms surged by 180%, around a $5.1bn increase, from 2024 to so far in 2025. The momentum in out-licensing was largely fuelled by billion-dollar agreements among large pharma companies such as Eli Lilly and GSK. Eli Lilly outlaid $630m for OliX Pharmaceuticals' metabolic-associated steatohepatitis (MASH) candidate in February and agreed a separate $1.3bn deal for biotech Rznomics' RNA-based gene therapies in May. GSK meanwhile licensed ABL Bios' blood-brain barrier shuttle platform for $2.8bn in April. GlobalData senior business fundamentals analyst Ophelia Chan says: 'Once primarily recognised for generic drug production, South Korea is now transitioning into a global hub for novel innovative drug discovery and advanced drug technologies, bolstered by government support and increasing international investment. This transition positions the country as a strategic bridge between Western and Asian markets.' In January 2025, South Korea established the National Bio Committee to make the country one of five global leaders in the bio industry by 2035. Part of this mandate is to enhance the country's competitiveness in novel drug and advanced biopharmaceutical technology development. According to South Korea's Ministry of Science and IT, the committee plans to create a Won1tn ($695.7m) fund to promote private investment in the biopharmaceutical and vaccine industry. The initiative builds on ongoing reforms as the government aims to reduce drug development timelines and costs, GlobalData said. South Korea joins China as a fast-growing destination for promising pipeline drug candidates. The total deal value of US licensing of innovator drug candidates from Chinese biopharma companies has surged 280% since 2020. A bipartisan report in the US has called for at least $15bn of funding over the next five years to avoid being eclipsed by China in biotech advancement. The future of the US and European pharma industries' relationship with Chinese and South Korean companies will require sturdy trade relationships between the regions. This has been stretched this year with tariffs imposed by President Donald Trump as his administration looks to bolster domestic manufacturing in the US. While licensing deals do not equate to imported products, Trump has maintained that transferring technology to China poses a threat to national security. The controversial BIOSECURE Act, which would have blacklisted Chinese biotechs and manufacturers from accessing US funding and collaborating with US pharma companies, is still in regulatory limbo. Another announcement made by the US Food and Drug Administration (FDA) was for an immediate review of new clinical trials that involve sending American citizens' living cells to China and other hostile countries for genetic engineering and subsequent infusion back into US patients. This move may potentially impact deals that pharma and biotech's have in place with Chinese contract development and manufacturing organisations (CDMOs). "Eli Lilly and GSK drive South Korea's drug licensing activity" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

How China is battling the chikungunya virus
How China is battling the chikungunya virus

Yahoo

time13 hours ago

  • Yahoo

How China is battling the chikungunya virus

When you buy through links on our articles, Future and its syndication partners may earn a commission. Killer fish, "cannibal" mosquitoes and drones are just three of the tactics that China is using to fight a new virus. After thousands of cases of the debilitating chikungunya infection were found across the southern Guangdong province, public health officials have been creative in their efforts to contain it. 'Compulsive killers' China employed hardline tactics during the Covid-19 pandemic and this time the authorities are using similar "patriotic public health" measures like mass testing, mandatory quarantines, widespread surveillance and citywide lockdowns. But they are also using more novel methods. The virus is transmitted by infected mosquitoes, so China is using giant "compulsive killers", known as elephant mosquitoes, whose larvae "devour" the Aedes mosquito, which passes chikungunya to people, said The Telegraph. A single larvae can consume a "staggering" number of mosquito larvae, up to several thousand, according to a paper published last year in the Journal of Tropical Medicine, and their "compulsive killing" and "predatory prowess" extend beyond "direct consumption" – after killing the mosquito larvae they "leave them uneaten". Mosquitoes aren't the only creatures being used. Researchers at Sun Yat-sen University in Guangdong have "deployed 5,000 larvae-eating fish, which consume the larvae that hatch in the city's lakes". Insecticide is being widely used and Chinese state television has shown masked soldiers spraying it "around city streets, residential areas, construction sites" and other areas, said The Associated Press. After "unusually" heavy rain and high temperatures "worsened the crisis", officials began using drones to "try to find standing water, where mosquitoes lay eggs". Meanwhile, community workers in red vests are going "door to door" to inspect homes, said The New York Times, and, according to local social media, they're ordering residents to empty all containers of water, including water bowls for their dogs. 'Bend over' The virus was first identified in Tanzania in 1952, and has since spread to 110 countries. It's most commonly found in sub-Saharan Africa, Southeast Asia and South America. It took its name from a Swahili dialect and translates approximately as "to bend over" – a reference to its debilitating symptoms. It is rarely fatal but it can cause fever, a rash and joint pain. It can also lead to severe illness in vulnerable groups such as newborn babies, the elderly and people with underlying medical conditions. Another 1,387 cases of chikungunya virus were confirmed in China last week, said the Daily Mail. This took the tally to more than 10,000 cases overall, with infections reported in Taiwan and Hong Kong, Europe and the US. But last week's figure was down on the previous seven-day tally of 2,892 cases, a sign that the outbreak could now be slowing. Solve the daily Crossword

The Race to Shrink Reactors and Grow Nuclear Power
The Race to Shrink Reactors and Grow Nuclear Power

Bloomberg

time13 hours ago

  • Bloomberg

The Race to Shrink Reactors and Grow Nuclear Power

Electricity demand is soaring, and some think the answer isn't building bigger, but smaller. That's the idea behind small modular reactors (SMRs): shrink a large and hard-to-build reactor to something that is, in theory, more manageable, cheaper and easier to replicate. These are early days for SMRs, with only two in commercial operation in Russia and China. Can SMRs ever become a solution for our energy needs and climate goals? Nuclear scientist and venture capitalist Rachel Slaybaugh joins Akshat Rathi on Zero to discuss.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store